Publication & Citation Trends
Publications
0 total
Transcriptional regulatory network analysis identifies GRN as a key regulator bridging chemotherapy and immunotherapy response in small cell lung cancer OA
Cited by 3
Semantic Scholar
TNG260 Is a Small-Molecule CoREST Inhibitor That Sensitizes STK11-Mutant Tumors to Anti–PD-1 Immunotherapy
Cited by 1
Semantic Scholar
681 TNG260, a novel small-molecule CoREST inhibitor, sensitizes STK11-mutant tumors to anti-PD-1 therapy
Cited by 0
Semantic Scholar
Abstract 4426: Chromatin constraints underpin adeno-to-squamous cell state transitions during acquired resistance to KRAS inhibition
Cited by 0
Semantic Scholar
Abstract 3916: TNG260, a small molecule CoREST inhibitor, sensitizes STK11-mutant NSCLC to anti-PD1 immunotherapy
Cited by 1
Semantic Scholar
Gene expression correlates of adagrasib response in KRASG12C mutated non-small cell lung cancer (NSCLC).
Cited by 0
Semantic Scholar
Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer. OA
Cited by 70
Semantic Scholar
Research Topics
DNA Repair Mechanisms
(3)
Genomics and Chromatin Dynamics
(3)
CRISPR and Genetic Engineering
(2)
Bacteriophages and microbial interactions
(2)
HIV Research and Treatment
(1)
Affiliations
Sunnybrook Health Science Centre
University of Toronto
The Scarborough Hospital
Sunnybrook Research Institute